Duration of dual antiplatelet therapy after implantation of drug-eluting stents

The study aims to evaluate the efficacy and benefits as well as risks of dual antiplatelet therapy in patients having undergone implantation of drug-eluting stents. The results indicate that such therapy used for a period longer than 12 months was found to be as effective as aspirin monotherapy in reducing the risk of myocardial infarction.